News

TNF Inhibitors Don't Boost Zoster Risk

Publish date: February 16, 2012

 

EXPERT ANALYSIS FROM A SYMPOSIUM SPONSORED BY THE AMERICAN COLLEGE OF RHEUMATOLOGY

Dr. Winthrop reported having no financial conflicts.

Pages

Recommended Reading

Shingles Vaccine Safe for Adults on Biologics
MDedge Dermatology
Vardenafil Increased Blood Flow in Raynaud Syndrome
MDedge Dermatology
Metabolic Syndrome Strikes Hard in Psoriatic Patients
MDedge Dermatology
FDA Advises Caution When IV Methotrexate-PPI Used Together
MDedge Dermatology
Don't Get Thrown for a Loop by Lyme Disease
MDedge Dermatology
Preterm Delivery a Risk in Systemic Sclerosis
MDedge Dermatology
Ondansetron Quells Methotrexate-Induced Nausea
MDedge Dermatology
FDA Issues Guidelines on Developing Biosimilar Products
MDedge Dermatology
Anticipate Mycobacterial Lung Disease in Anti-TNF Users
MDedge Dermatology
New Insights Gained Into Biologics' Infection Risk
MDedge Dermatology